Mutations in the MPV17 gene are responsible for rapidly progressive liver failure in infancy

Lee-Jun C Wong1, Nicola Brunetti-Pierri, Qing Zhang

  • 1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA. ljwong@bcm.edu

Abstract

Insights

Mutations in the MPV17 gene cause mitochondrial DNA depletion syndrome. This study highlights MPV17 mutations as a key cause of infantile liver failure, even without neurological symptoms.

Area of Science:

  • Mitochondrial biology
  • Genetics
  • Hepatology

Background:

  • MPV17 is a mitochondrial inner membrane protein.
  • MPV17 mutations are linked to mitochondrial DNA depletion syndrome.
  • The precise function of MPV17 and its role in disease are not fully understood.

Observation:

  • This study investigated 4 cases from 3 families with MPV17 gene mutations.
  • Two cases presented with isolated infantile liver failure.
  • Neurological dysfunction was not a prominent feature in these cases.

Findings:

  • MPV17 mutations lead to mitochondrial DNA depletion.
  • Clinical presentation includes severe liver dysfunction.
  • Pathological and biochemical features are associated with MPV17 mutations.

Implications:

  • MPV17 gene mutations should be considered in diagnosing infantile liver failure.
  • Early molecular diagnosis can guide patient management.
  • Understanding MPV17 function is crucial for developing targeted therapies.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Translation01:31

Translation

Lesson: Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life